Cargando…

Cancer biomarkers and targeted therapies

Detalles Bibliográficos
Autor principal:	Shen, Zhiyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599874/ https://www.ncbi.nlm.nih.gov/pubmed/23388145 http://dx.doi.org/10.1186/2045-3701-3-6

Ejemplares similares

Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
por: Karachaliou, Niki, et al.
Publicado: (2015)

Expanding the landscape of TCR gene therapy targeting MAGE
por: Mao, Zhiyuan, et al.
Publicado: (2023)

Epigenetics in rhabdomyosarcoma: cues to new biomarkers and targeted therapies
por: Megiorni, Francesca
Publicado: (2020)

SGK1 in Cancer: Biomarker and Drug Target
por: Cicenas, Jonas, et al.
Publicado: (2022)

The missing middle of sickle therapeutics: Multi‐agent therapy, targeting risk, using biomarkers
por: Hebbel, Robert P., et al.
Publicado: (2018)

Mucosal Lining Fluid Biomarkers in Asthma: Basis for Rational Use of New Targeted Therapies?
por: Valenta, Rudolf
Publicado: (2017)

Transgelin in bladder cancer: A potential biomarker and therapeutic target
por: Li, Wei-Ming, et al.
Publicado: (2019)

Pancreatic Cancer: Targeted Therapy Holds the Promise
por: Zhou, Zhijun, et al.
Publicado: (2021)

Advances in Chemotherapy and Targeted Therapies in Endometrial Cancer
por: Chambers, Setsuko K.
Publicado: (2022)

Novel mechanism of resistance to targeted therapies in lung cancer
por: Wang, Walter, et al.
Publicado: (2018)

Disulfidptosis: a new target for metabolic cancer therapy
por: Zheng, Peijie, et al.
Publicado: (2023)

Beta-adrenergic signaling, a novel target for cancer therapy?
por: Schuller, Hildegard M.
Publicado: (2010)

Hypoxia-specific targets in cancer therapy: role of splice variants
por: Vordermark, Dirk
Publicado: (2010)

RNA nanoparticles for targeted therapies of triple-negative breast cancers
por: Danai, Leyla, et al.
Publicado: (2023)

Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?
por: Peinetti, Nahuel, et al.
Publicado: (2022)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

Finding a Place for Tumor-specific T Cells in Targeted Cancer Therapy
por: Riddell, Stanley R.
Publicado: (2004)

Citrate targets FBPase and constitutes an emerging novel approach for cancer therapy
por: Icard, Philippe, et al.
Publicado: (2018)

Small molecule targeting miR-34a for cancer therapy
por: Xiao, Zhangang, et al.
Publicado: (2015)

Molecular Biomarkers of Oxygen Therapy in Patients with Diabetic Foot Ulcers
por: Oropallo, Alisha R., et al.
Publicado: (2021)

Towards Targeted Brain Stimulation in Stroke: Connectivity as a Biomarker of Response
por: Hordacre, Brenton, et al.
Publicado: (2018)

Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both?
por: Cantarelli, Chiara, et al.
Publicado: (2021)

Targeting CDC34 E2 ubiquitin conjugating enzyme for lung cancer therapy
por: Zhang, Shizhen, et al.
Publicado: (2020)

Intratumoral heterogeneity after targeted therapy in murine cancer models with differing degrees of malignancy
por: Gerwing, M., et al.
Publicado: (2023)

Lymphatic Vessels as Targets of Tumor Therapy?
por: Karpanen, Terhi, et al.
Publicado: (2001)

Cytokine Targeted Therapy for Dupuytren's Disease
por: Satish, Latha
Publicado: (2018)

TSLP‐targeting therapy: Beyond allergy?
por: Ebina‐Shibuya, Risa, et al.
Publicado: (2023)

Circulating prostaglandins as biomarkers for colorectal cancer?
por: Greenhough, Alexander, et al.
Publicado: (2015)

Lipidomics: a promising cancer biomarker
por: Yan, Furong, et al.
Publicado: (2018)

Targeted Endocrine Agents should be the Dominant Systemic Therapies Prescribed in Luminal A Breast Cancer
por: Davey, Matthew G, et al.
Publicado: (2023)

Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers
por: Hobson, Michael J, et al.
Publicado: (2011)

Plasmalemmal V-ATPase as a Potential Biomarker for Lactoferrin-Based Anticancer Therapy
por: Santos-Pereira, Cátia, et al.
Publicado: (2022)

Plasma-type gelsolin in subarachnoid hemorrhage: novel biomarker today, therapeutic target tomorrow?
por: Chou, Sherry Hsiang-Yi, et al.
Publicado: (2014)

Biomarkers That Predict Diabetic Nephropathy: The Long Road From Finding Targets to Clinical Use
por: Klein, Jon
Publicado: (2012)

Targeting mucin hypersecretion in COVID-19 therapy
por: Prasher, Parteek, et al.
Publicado: (2022)

Demonstrating the value of cancer biomarkers at the population level
por: Gandjour, Afschin
Publicado: (2022)

PP2A Level in Colorectal Cancer Cells Predicts the Response of p38 Targeted Therapy
por: Shang, Chaowei, et al.
Publicado: (2015)

Targeting multimorbidity: Using healthspan and lifespan to identify biomarkers of ageing that pinpoint shared disease mechanisms
por: Deelen, Joris
Publicado: (2021)

Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers
por: Akiyama, Tetsuya, et al.
Publicado: (2022)

Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
por: Ostermann, Marlies, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l55hh1886r8kn3ee8gqlskou4b